Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria
- PMID: 12678693
- DOI: 10.2174/1389200033489505
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria
Abstract
Trimethylaminuria is a rare metabolic disorder that is associated with abnormal amounts of the dietary-derived trimethylamine. Excess unmetabolized trimethylamine in the urine, sweat and other body secretions confers a strong, foul body odor that can affect the individual's ability to work or engage in social activities. This review summarizes the biochemical aspects of the condition and the classification of the disorder into: 1) primary genetic form, 2) acquired form, 3) childhood forms, 4) transient form associated with menstruation, 5) precursor overload and 6) disease states. The genetic variability of the flavin-containing monooxygenase (form 3) that is responsible for detoxication and deodoration of trimethylamine is discussed and put in context with other variant forms of the flavin-containing monooxygenase (forms 1-5). The temporal-selective expression of flavin-containing monooxygenase forms 1 and 3 is discussed in terms of an explanation for childhood trimethylaminuria. Information as to whether variants of the flavin-containing monooxygenase form 3 contributes to hypertension and/or other diseases are presented. Discussion is provided outlining recent bioanalytical approaches to quantify urinary trimethylamine and trimethylamine N-oxide and plasma choline as well as data on self-reporting individuals tested for trimethylaminuria. Finally, trimethylaminuria treatment strategies and nutritional support are described including dietary sources of trimethylamine, vitamin supplementation and drug treatment and issues related to trimethylaminuria in pregnancy and lactation are discussed. The remarkable progress in the biochemical, genetic, clinical basis for understanding the trimethylaminuria condition is summarized and points to needs in the treatment of individuals suffering from trimethylaminuria.
Similar articles
-
Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.Chem Res Toxicol. 1997 Aug;10(8):837-41. doi: 10.1021/tx9700533. Chem Res Toxicol. 1997. PMID: 9282831
-
Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.Gene. 2013 Sep 15;527(1):366-70. doi: 10.1016/j.gene.2013.05.025. Epub 2013 Jun 17. Gene. 2013. PMID: 23791655
-
Transient trimethylaminuria related to menstruation.BMC Med Genet. 2007 Jan 27;8:2. doi: 10.1186/1471-2350-8-2. BMC Med Genet. 2007. PMID: 17257434 Free PMC article.
-
Treatments of trimethylaminuria: where we are and where we might be heading.Drug Discov Today. 2020 Sep;25(9):1710-1717. doi: 10.1016/j.drudis.2020.06.026. Epub 2020 Jun 29. Drug Discov Today. 2020. PMID: 32615074 Review.
-
[Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-].Yakugaku Zasshi. 2009 Nov;129(11):1351-6. doi: 10.1248/yakushi.129.1351. Yakugaku Zasshi. 2009. PMID: 19881207 Review. Japanese.
Cited by
-
Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.Arch Biochem Biophys. 2007 Aug 15;464(2):251-9. doi: 10.1016/j.abb.2007.04.014. Epub 2007 May 2. Arch Biochem Biophys. 2007. PMID: 17531949 Free PMC article.
-
Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.APMIS. 2020 May;128(5):353-366. doi: 10.1111/apm.13038. Epub 2020 Mar 30. APMIS. 2020. PMID: 32108960 Free PMC article. Review.
-
A review of trimethylaminuria: (fish odor syndrome).J Clin Aesthet Dermatol. 2013 Nov;6(11):45-8. J Clin Aesthet Dermatol. 2013. PMID: 24307925 Free PMC article. Review.
-
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.Cell. 2015 Dec 17;163(7):1585-95. doi: 10.1016/j.cell.2015.11.055. Cell. 2015. PMID: 26687352 Free PMC article.
-
Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis.Mol Med. 2024 Aug 23;30(1):128. doi: 10.1186/s10020-024-00895-8. Mol Med. 2024. PMID: 39180015 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical